[
  {
    "title": "前沿生物(688221.SH)：目前正积极加速推进注射用FB2001拟治疗新冠病毒感染住院患者的II/III期临床试验等",
    "href": "http://stock.jrj.com.cn/2023/01/02173037253230.shtml",
    "datetime": "2023-01-02 17:30:58",
    "code": "688221"
  },
  {
    "title": "前沿生物：注射用FB2001用于新冠病毒感染患者的II/III期临床试验已获批准",
    "href": "http://stock.jrj.com.cn/2023/01/02172537253212.shtml",
    "datetime": "2023-01-02 17:25:28",
    "code": "688221"
  },
  {
    "title": "A股异动 | 前沿生物-U涨近6% 与鱼跃医疗拟在生命科学领域进一步开展药械合作",
    "href": "http://stock.jrj.com.cn/2022/12/09104037200642.shtml",
    "datetime": "2022-12-09 10:40:41",
    "code": "688221"
  },
  {
    "title": "前沿生物(688221.SH)：与鱼跃医疗签署战略合作协议 拟在生命科学领域进一步开展药械合作等",
    "href": "http://stock.jrj.com.cn/2022/12/08182537199036.shtml",
    "datetime": "2022-12-08 18:25:19",
    "code": "688221"
  },
  {
    "title": "前沿生物：与鱼跃医疗就雾化吸入用FB2001达成战略合作意向",
    "href": "http://stock.jrj.com.cn/2022/12/08182037199011.shtml",
    "datetime": "2022-12-08 18:20:42",
    "code": "688221"
  },
  {
    "title": "前沿生物(688221.SH)：签订艾可宁原料药长单采购合同 采购总额不超1.8亿元",
    "href": "http://stock.jrj.com.cn/2022/11/25172737167267.shtml",
    "datetime": "2022-11-25 17:27:47",
    "code": "688221"
  },
  {
    "title": "前沿生物：签订艾可宁补充采购合同",
    "href": "http://stock.jrj.com.cn/2022/11/25172137167239.shtml",
    "datetime": "2022-11-25 17:21:33",
    "code": "688221"
  },
  {
    "title": "A股异动 | 前沿生物高开13% 雾化吸入用FB2001获批开展Ⅱ/Ⅲ期临床试验",
    "href": "http://stock.jrj.com.cn/2022/11/24092937162692.shtml",
    "datetime": "2022-11-24 09:29:24",
    "code": "688221"
  },
  {
    "title": "前沿生物：雾化吸入用FB2001获批开展Ⅱ/Ⅲ期临床试验",
    "href": "http://stock.jrj.com.cn/2022/11/23170937161003.shtml",
    "datetime": "2022-11-23 17:09:48",
    "code": "688221"
  },
  {
    "title": "前沿生物：雾化吸入用FB2001获批开展Ⅱ/Ⅲ期临床试验",
    "href": "http://stock.jrj.com.cn/2022/11/23165037160948.shtml",
    "datetime": "2022-11-23 16:50:22",
    "code": "688221"
  },
  {
    "title": "前沿生物(688221.SH)：雾化吸入用FB2001获批开展Ⅱ/Ⅲ期临床试验",
    "href": "http://stock.jrj.com.cn/2022/11/23164837160936.shtml",
    "datetime": "2022-11-23 16:48:32",
    "code": "688221"
  },
  {
    "title": "前沿生物(SH.688221): 三季度业绩释放加速，科创内核驱动长期成长",
    "href": "http://stock.jrj.com.cn/2022/10/30180437097577.shtml",
    "datetime": "2022-10-30 18:04:59",
    "code": "688221"
  },
  {
    "title": "前沿生物2022年前三季度亏损2.27亿同比亏损增加 FB2001项目投入增幅较大",
    "href": "http://stock.jrj.com.cn/2022/10/25211137083298.shtml",
    "datetime": "2022-10-25 21:11:40",
    "code": "688221"
  },
  {
    "title": "前沿生物(688221.SH)第三季度实现营收3149.22万元、同比增长166.12%",
    "href": "http://stock.jrj.com.cn/2022/10/25163537081826.shtml",
    "datetime": "2022-10-25 16:35:54",
    "code": "688221"
  },
  {
    "title": "前沿生物：艾可宁增加静脉推注给药方式的药品补充申请获批",
    "href": "http://stock.jrj.com.cn/2022/10/20182237070766.shtml",
    "datetime": "2022-10-20 18:22:11",
    "code": "688221"
  },
  {
    "title": "前沿生物(688221.SH)：艾可宁增加静脉推注给药方式药品补充申请获批准",
    "href": "http://stock.jrj.com.cn/2022/10/20175937070646.shtml",
    "datetime": "2022-10-20 17:59:29",
    "code": "688221"
  },
  {
    "title": "前沿生物：雾化吸入用FB2001获药物临床试验批准通知书",
    "href": "http://stock.jrj.com.cn/2022/09/26184737022506.shtml",
    "datetime": "2022-09-26 18:47:10",
    "code": "688221"
  },
  {
    "title": "前沿生物：雾化吸入用FB2001获得药物临床试验批准通知书",
    "href": "http://stock.jrj.com.cn/2022/09/26184337022451.shtml",
    "datetime": "2022-09-26 18:43:36",
    "code": "688221"
  },
  {
    "title": "前沿生物：实际控制人控股比例被动稀释超过1%",
    "href": "http://stock.jrj.com.cn/2022/09/22105637013406.shtml",
    "datetime": "2022-09-22 10:56:23",
    "code": "688221"
  },
  {
    "title": "前沿生物：雾化吸入用FB2001药品注册临床试验申请获受理",
    "href": "http://stock.jrj.com.cn/2022/09/13184336991930.shtml",
    "datetime": "2022-09-13 18:43:47",
    "code": "688221"
  },
  {
    "title": "前沿生物(688221.SH)：雾化吸入用FB2001药品注册临床试验申请获得受理",
    "href": "http://stock.jrj.com.cn/2022/09/13182936991903.shtml",
    "datetime": "2022-09-13 18:29:07",
    "code": "688221"
  },
  {
    "title": "前沿生物：艾可宁在马来西亚获药品上市注册批准",
    "href": "http://stock.jrj.com.cn/2022/09/09172136986891.shtml",
    "datetime": "2022-09-09 17:21:39",
    "code": "688221"
  },
  {
    "title": "前沿生物(688221.SH)：艾可宁在马来西亚获得药品上市注册批准",
    "href": "http://stock.jrj.com.cn/2022/09/09171936986864.shtml",
    "datetime": "2022-09-09 17:19:09",
    "code": "688221"
  },
  {
    "title": "前沿生物(688221.SH)披露简易程序定增结果：杰正投资、诺德基金及UBS AG等参投",
    "href": "http://stock.jrj.com.cn/2022/09/08180836983883.shtml",
    "datetime": "2022-09-08 18:08:05",
    "code": "688221"
  },
  {
    "title": "前沿生物半年报：核心产品销售稳步增长 推进多产品管线布局取得实效",
    "href": "http://stock.jrj.com.cn/2022/08/31080036956169.shtml",
    "datetime": "2022-08-31 08:00:55",
    "code": "688221"
  },
  {
    "title": "前沿生物：新冠药FB2001具有良好的临床安全性和耐受性",
    "href": "http://stock.jrj.com.cn/2022/08/09154436882767.shtml",
    "datetime": "2022-08-09 15:44:38",
    "code": "688221"
  },
  {
    "title": "前沿生物(688221.SH)在2022年新发传染病国际会议(ICEID)报告抗新冠病毒药物FB2001最新临床数据",
    "href": "http://stock.jrj.com.cn/2022/08/09154136882825.shtml",
    "datetime": "2022-08-09 15:41:50",
    "code": "688221"
  },
  {
    "title": "瑞银证券原保代崔健民离职，曾参与前沿生物-U、世运电路等IPO项目",
    "href": "http://stock.jrj.com.cn/2022/08/02133036862492.shtml",
    "datetime": "2022-08-02 13:30:30",
    "code": "688221"
  },
  {
    "title": "前沿生物(688221.SH)：以简易程序向特定对象发行股票申请获上交所审核通过",
    "href": "http://stock.jrj.com.cn/2022/08/01155536859232.shtml",
    "datetime": "2022-08-01 15:55:51",
    "code": "688221"
  },
  {
    "title": "前沿生物(688221.SH)：以简易程序向特定对象发行股票申请获上交所受理",
    "href": "http://stock.jrj.com.cn/2022/07/27174636847515.shtml",
    "datetime": "2022-07-27 17:46:29",
    "code": "688221"
  },
  {
    "title": "前沿生物(688221.SH)：艾可宁增加静脉推注给药方式的药品补充申请获得受理",
    "href": "http://stock.jrj.com.cn/2022/07/19180336825763.shtml",
    "datetime": "2022-07-19 18:03:25",
    "code": "688221"
  },
  {
    "title": "奥密克戎变种来袭，前沿生物-U（688221.SH）打出“治疗与预防”组合拳",
    "href": "http://stock.jrj.com.cn/2022/07/17095936818267.shtml",
    "datetime": "2022-07-17 09:59:04",
    "code": "688221"
  },
  {
    "title": "前沿生物(688221.SH)：拟与凯莱英在新冠3CL蛋白酶抑制剂产品FB2001建立战略合作",
    "href": "http://stock.jrj.com.cn/2022/07/14230036813367.shtml",
    "datetime": "2022-07-14 23:00:56",
    "code": "688221"
  },
  {
    "title": "前沿生物：拟与凯莱英在新冠3CL蛋白酶抑制剂产品FB2001建立战略合作",
    "href": "http://stock.jrj.com.cn/2022/07/14173936811814.shtml",
    "datetime": "2022-07-14 17:39:45",
    "code": "688221"
  },
  {
    "title": "前沿生物(688221.SH)：注射抗HIV融合抑制剂艾可宁位于南京乾德路的生产基地获得PIC/SGMP认证",
    "href": "http://stock.jrj.com.cn/2022/06/10174436719882.shtml",
    "datetime": "2022-06-10 17:44:39",
    "code": "688221"
  },
  {
    "title": "前沿生物(688221)：股东减持股份结果",
    "href": "http://stock.jrj.com.cn/2022/05/30084036688058.shtml",
    "datetime": "2022-05-30 08:40:07",
    "code": "688221"
  },
  {
    "title": "前沿生物股东南京晟功减持1435.79万股 套现2.23亿 2021年公司亏损2.6亿",
    "href": "http://stock.jrj.com.cn/2022/05/27205336686102.shtml",
    "datetime": "2022-05-27 20:53:21",
    "code": "688221"
  },
  {
    "title": "前沿生物(688221.SH)：减持期届满 南京晟功累计减持3.99%股份",
    "href": "http://stock.jrj.com.cn/2022/05/27173636685120.shtml",
    "datetime": "2022-05-27 17:36:27",
    "code": "688221"
  },
  {
    "title": "前沿生物选举谢东为董事长 2021年公司亏损2.6亿",
    "href": "http://stock.jrj.com.cn/2022/05/24221036675674.shtml",
    "datetime": "2022-05-24 22:10:56",
    "code": "688221"
  },
  {
    "title": "前沿生物(688221.SH)：艾可宁获批阿塞拜疆上市",
    "href": "http://stock.jrj.com.cn/2022/05/20160036665760.shtml",
    "datetime": "2022-05-20 16:00:22",
    "code": "688221"
  },
  {
    "title": "前沿生物披露2021年年报 实现营收4050.29万元",
    "href": "http://stock.jrj.com.cn/2022/05/05085236565929.shtml",
    "datetime": "2022-05-05 08:52:12",
    "code": "688221"
  },
  {
    "title": "前沿生物披露2022年一季报 实现营收567.03万元",
    "href": "http://stock.jrj.com.cn/2022/05/05085136565931.shtml",
    "datetime": "2022-05-05 08:51:45",
    "code": "688221"
  },
  {
    "title": "抗新冠药物FB2001能否助力前沿生物甩掉“阿斗”的帽子？",
    "href": "http://stock.jrj.com.cn/2022/05/02112236530135.shtml",
    "datetime": "2022-05-02 11:22:00",
    "code": "688221"
  },
  {
    "title": "前沿生物(688221.SH)一季度净亏损5924.16万元",
    "href": "http://stock.jrj.com.cn/2022/04/29204136507393.shtml",
    "datetime": "2022-04-29 20:41:17",
    "code": "688221"
  },
  {
    "title": "前沿生物(688221.SH)2021年度净亏损2.6亿元",
    "href": "http://stock.jrj.com.cn/2022/04/29203936507289.shtml",
    "datetime": "2022-04-29 20:39:26",
    "code": "688221"
  },
  {
    "title": "前沿生物：拟定增募资不超3亿元用于新冠药FB2001研发项目",
    "href": "http://stock.jrj.com.cn/2022/04/29194236506742.shtml",
    "datetime": "2022-04-29 19:42:00",
    "code": "688221"
  },
  {
    "title": "前沿生物(688221.SH)：新冠小分子药物FB2001获批开展Ⅱ/Ⅲ期国际多中心临床试验",
    "href": "http://stock.jrj.com.cn/2022/04/27230536487445.shtml",
    "datetime": "2022-04-27 23:05:50",
    "code": "688221"
  },
  {
    "title": "前沿生物(688221.SH)：众诚鸿运完成减持3.29%股份",
    "href": "http://stock.jrj.com.cn/2022/04/15173736345417.shtml",
    "datetime": "2022-04-15 17:37:18",
    "code": "688221"
  },
  {
    "title": "前沿生物(688221.SH)：获得高新技术企业证书",
    "href": "http://stock.jrj.com.cn/2022/03/31163536239879.shtml",
    "datetime": "2022-03-31 16:35:10",
    "code": "688221"
  },
  {
    "title": "前沿生物2021年亏损2.66亿同比亏损增加 研发费用及销售费用增幅较大",
    "href": "http://stock.jrj.com.cn/2022/02/25215134468570.shtml",
    "datetime": "2022-02-25 21:51:33",
    "code": "688221"
  },
  {
    "title": "前沿生物(688221.SH)：2021年度预亏2.6亿元-2.9亿元",
    "href": "http://stock.jrj.com.cn/2022/01/28211834248756.shtml",
    "datetime": "2022-01-28 21:18:37",
    "code": "688221"
  },
  {
    "title": "A股异动 | 前沿生物涨9% 产品FB2001拟用于治疗中、重度新冠肺炎住院患者",
    "href": "http://stock.jrj.com.cn/2022/01/18110434168724.shtml",
    "datetime": "2022-01-18 11:04:18",
    "code": "688221"
  },
  {
    "title": "前沿生物(688221.SH)：产品FB2001拟用于治疗中、重度的新冠肺炎住院患者",
    "href": "http://stock.jrj.com.cn/2022/01/17234434166928.shtml",
    "datetime": "2022-01-17 23:44:15",
    "code": "688221"
  },
  {
    "title": "前沿生物：产品FB2001拟用于治疗中、重度的新冠肺炎住院患者",
    "href": "http://stock.jrj.com.cn/2022/01/17204134166106.shtml",
    "datetime": "2022-01-17 20:41:38",
    "code": "688221"
  },
  {
    "title": "前沿生物(688221.SH)：上海众诚鸿运近日累计减持105.22万股 持股降至5%以下",
    "href": "http://stock.jrj.com.cn/2022/01/07172634134066.shtml",
    "datetime": "2022-01-07 17:26:58",
    "code": "688221"
  },
  {
    "title": "前沿生物(688221.SH)：众诚鸿运拟减持不超1183.61万股",
    "href": "http://stock.jrj.com.cn/2021/12/26162034062027.shtml",
    "datetime": "2021-12-26 16:20:43",
    "code": "688221"
  },
  {
    "title": "前沿生物：众诚鸿运拟减持不超3.29%股份",
    "href": "http://stock.jrj.com.cn/2021/12/26160134061992.shtml",
    "datetime": "2021-12-26 16:01:10",
    "code": "688221"
  },
  {
    "title": "前沿生物(688221.SH)：南京晟功累计减持184.16万股 持股降至5%以下",
    "href": "http://stock.jrj.com.cn/2021/12/10210633996174.shtml",
    "datetime": "2021-12-10 21:06:40",
    "code": "688221"
  },
  {
    "title": "前沿生物抗新冠病毒药物FB2001获得临床试验批准",
    "href": "http://stock.jrj.com.cn/2021/12/10193033995709.shtml",
    "datetime": "2021-12-10 19:30:57",
    "code": "688221"
  },
  {
    "title": "前沿生物(688221.SH)：抗新冠病毒药物注射用FB2001的药物临床I期桥接试验申请获批",
    "href": "http://stock.jrj.com.cn/2021/12/10191433995664.shtml",
    "datetime": "2021-12-10 19:14:11",
    "code": "688221"
  },
  {
    "title": "前沿生物：抗新冠病毒药物FB2001获得临床试验批准",
    "href": "http://stock.jrj.com.cn/2021/12/10190733995640.shtml",
    "datetime": "2021-12-10 19:07:49",
    "code": "688221"
  },
  {
    "title": "前沿生物(688221.SH)：注射用艾博韦泰增加静脉推注给药方式的药物临床试验补充申请获得批准",
    "href": "http://stock.jrj.com.cn/2021/12/07173133980617.shtml",
    "datetime": "2021-12-07 17:31:15",
    "code": "688221"
  },
  {
    "title": "前沿生物大股东清仓近2000万股 靠一款药撑业绩 至今仍未盈利",
    "href": "http://stock.jrj.com.cn/2021/11/08082933822115.shtml",
    "datetime": "2021-11-08 08:29:00",
    "code": "688221"
  },
  {
    "title": "前沿生物(688221.SH)：南京晟功拟减持不超5.51%的股份",
    "href": "http://stock.jrj.com.cn/2021/11/05170033817249.shtml",
    "datetime": "2021-11-05 17:00:35",
    "code": "688221"
  },
  {
    "title": "A股异动 | 前沿生物(688221.SH)跌逾4% 约1.0095亿股限售股将解禁",
    "href": "http://stock.jrj.com.cn/2021/10/21105933725979.shtml",
    "datetime": "2021-10-21 10:59:51",
    "code": "688221"
  },
  {
    "title": "前沿生物(688221.SH)：约1.0095亿股限售股将解禁",
    "href": "http://stock.jrj.com.cn/2021/10/20163033722011.shtml",
    "datetime": "2021-10-20 16:30:55",
    "code": "688221"
  },
  {
    "title": "前沿生物亮相中国医药创新与投资大会 中国创新药国际化未来可期",
    "href": "http://stock.jrj.com.cn/2021/10/20150033721472.shtml",
    "datetime": "2021-10-20 15:00:35",
    "code": "688221"
  },
  {
    "title": "前沿生物：公司海外布局提速 跨入全球市场第二站",
    "href": "http://stock.jrj.com.cn/2021/10/19145433716186.shtml",
    "datetime": "2021-10-19 14:54:09",
    "code": "688221"
  },
  {
    "title": "前沿生物新增静脉推注剂型 艾可宁市场空间有望进一步扩大",
    "href": "http://stock.jrj.com.cn/2021/10/18164433711234.shtml",
    "datetime": "2021-10-18 16:44:19",
    "code": "688221"
  },
  {
    "title": "前沿生物(688221.SH)：拟使用不超13亿元闲置募集资金进行现金管理",
    "href": "http://stock.jrj.com.cn/2021/10/15203933700248.shtml",
    "datetime": "2021-10-15 20:39:28",
    "code": "688221"
  },
  {
    "title": "前沿生物(688221.SH)：前三季度净亏损达1.77亿元",
    "href": "http://stock.jrj.com.cn/2021/10/15163433698774.shtml",
    "datetime": "2021-10-15 16:34:28",
    "code": "688221"
  },
  {
    "title": "A股异动 | 前沿生物(688221.SH)涨超4% 艾可宁增加静脉推注给药方式临床试验申请获受理",
    "href": "http://stock.jrj.com.cn/2021/10/08103733656300.shtml",
    "datetime": "2021-10-08 10:37:00",
    "code": "688221"
  },
  {
    "title": "前沿生物(688221.SH)：获得艾可宁增加静脉推注给药方式的临床试验补充申请受理通知书",
    "href": "http://stock.jrj.com.cn/2021/09/30163733543328.shtml",
    "datetime": "2021-09-30 16:37:23",
    "code": "688221"
  },
  {
    "title": "前沿生物(688221.SH)：艾可宁获得柬埔寨药品注册证书",
    "href": "http://stock.jrj.com.cn/2021/09/22172033499394.shtml",
    "datetime": "2021-09-22 17:20:57",
    "code": "688221"
  },
  {
    "title": "前沿生物公布2021年度半年报 加快国际化市场进程",
    "href": "http://stock.jrj.com.cn/2021/08/31152833361290.shtml",
    "datetime": "2021-08-31 15:28:49",
    "code": "688221"
  },
  {
    "title": "前沿生物2021半年度营业收入稳定增长 获机构股东增持",
    "href": "http://stock.jrj.com.cn/kcb/2021/08/20141833286754.shtml",
    "datetime": "2021-08-20 14:18:09",
    "code": "688221"
  },
  {
    "title": "前沿生物2021年半年度亏损9344.56万元 同比亏损减少",
    "href": "http://stock.jrj.com.cn/2021/08/16184733261863.shtml",
    "datetime": "2021-08-16 18:47:55",
    "code": "688221"
  },
  {
    "title": "前沿生物(688221.SH)：上半年净亏损9344.5万元",
    "href": "http://stock.jrj.com.cn/2021/08/16182433261686.shtml",
    "datetime": "2021-08-16 18:24:41",
    "code": "688221"
  },
  {
    "title": "前沿生物：若公司能够取得“稳定的艾博韦泰组合物”的中国及国际专利 保护期限为2019年-2039年",
    "href": "http://stock.jrj.com.cn/2021/06/18195132956337.shtml",
    "datetime": "2021-06-18 19:51:43",
    "code": "688221"
  },
  {
    "title": "前沿生物：2020年度未产生应纳税所得 所得税为零 待公司盈利后 所得税率为25%",
    "href": "http://stock.jrj.com.cn/2021/06/18194132956237.shtml",
    "datetime": "2021-06-18 19:41:25",
    "code": "688221"
  },
  {
    "title": "A股异动 | 前沿生物(688221.SH)涨超6% 新冠候选新药FB2001在美启动I期临床试验",
    "href": "http://stock.jrj.com.cn/2021/05/26094432821346.shtml",
    "datetime": "2021-05-26 09:44:14",
    "code": "688221"
  },
  {
    "title": "前沿生物(688221.SH)：新冠候选新药FB2001在美启动I期临床试验",
    "href": "http://stock.jrj.com.cn/2021/05/25181932817434.shtml",
    "datetime": "2021-05-25 18:19:28",
    "code": "688221"
  },
  {
    "title": "前沿生物：新冠病毒候选新药FB2001已启动I期临床试验",
    "href": "http://stock.jrj.com.cn/2021/05/25181332817397.shtml",
    "datetime": "2021-05-25 18:13:56",
    "code": "688221"
  },
  {
    "title": "锂电池概念热度高机构力捧 前沿生物低位反弹游资抢筹",
    "href": "http://stock.jrj.com.cn/2021/05/19082932780278.shtml",
    "datetime": "2021-05-19 08:29:46",
    "code": "688221"
  },
  {
    "title": "前沿生物(688221.SH)：一季度亏损收窄 净亏损4481.89万元",
    "href": "http://stock.jrj.com.cn/2021/04/28220932474620.shtml",
    "datetime": "2021-04-28 22:09:09",
    "code": "688221"
  },
  {
    "title": "前沿生物：艾可宁制剂及原料药的药品上市许可人工作正在有序推进中",
    "href": "http://stock.jrj.com.cn/2021/04/26162932454497.shtml",
    "datetime": "2021-04-26 16:29:34",
    "code": "688221"
  },
  {
    "title": "前沿生物：公司暂未开展与医疗美容相关的业务",
    "href": "http://stock.jrj.com.cn/2021/04/26162932454496.shtml",
    "datetime": "2021-04-26 16:29:29",
    "code": "688221"
  },
  {
    "title": "前沿生物(688221.SH)：440.74万股首发限售股4月28日解禁",
    "href": "http://stock.jrj.com.cn/2021/04/19172932402870.shtml",
    "datetime": "2021-04-19 17:29:32",
    "code": "688221"
  },
  {
    "title": "前沿生物：目前公司尚未达到股票回购的条件",
    "href": "http://stock.jrj.com.cn/2021/04/13110732363565.shtml",
    "datetime": "2021-04-13 11:07:25",
    "code": "688221"
  },
  {
    "title": "营收增长仍旧亏损！前沿生物去年亏损2.31亿",
    "href": "http://stock.jrj.com.cn/2021/03/31105232254449.shtml",
    "datetime": "2021-03-31 10:52:12",
    "code": "688221"
  },
  {
    "title": "前沿生物(688221.SH)2020年度净亏损2.31亿元",
    "href": "http://stock.jrj.com.cn/2021/03/30215932249968.shtml",
    "datetime": "2021-03-30 21:59:23",
    "code": "688221"
  },
  {
    "title": "前沿生物：艾可宁获得厄瓜多尔药品注册证书",
    "href": "http://stock.jrj.com.cn/2021/03/18101032155762.shtml",
    "datetime": "2021-03-18 10:10:01",
    "code": "688221"
  },
  {
    "title": "前沿生物(688221.SH)：艾可宁获厄瓜多尔药品注册证书",
    "href": "http://stock.jrj.com.cn/2021/03/17174032151956.shtml",
    "datetime": "2021-03-17 17:40:45",
    "code": "688221"
  },
  {
    "title": "继续亏损！前沿生物亏损幅度进一步扩大增至2.31亿元",
    "href": "http://stock.jrj.com.cn/2021/02/26140332032526.shtml",
    "datetime": "2021-02-26 14:03:23",
    "code": "688221"
  },
  {
    "title": "前沿生物(688221.SH)业绩快报：2020年营收4662.28万元 同比增长123.50%",
    "href": "http://stock.jrj.com.cn/2021/02/25175532026730.shtml",
    "datetime": "2021-02-25 17:55:46",
    "code": "688221"
  },
  {
    "title": "为支持生产基地项目建设，前沿生物为四川前沿、齐河前沿不超6亿元授信额度提供担保",
    "href": "http://stock.jrj.com.cn/2021/02/02103931835293.shtml",
    "datetime": "2021-02-02 10:39:41",
    "code": "688221"
  },
  {
    "title": "前沿生物2020年预计亏损2.2亿-2.4亿 研发费用增长",
    "href": "http://stock.jrj.com.cn/2021/01/22150731744751.shtml",
    "datetime": "2021-01-22 15:07:57",
    "code": "688221"
  },
  {
    "title": "亏损扩大！前沿生物预计2020年归母净利润亏损超2.2亿元",
    "href": "http://stock.jrj.com.cn/2021/01/21083631734206.shtml",
    "datetime": "2021-01-21 08:36:28",
    "code": "688221"
  },
  {
    "title": "前沿生物首发五套标准上市公司业绩预告 成绩可圈可点",
    "href": "http://stock.jrj.com.cn/2021/01/20190331730640.shtml",
    "datetime": "2021-01-20 19:03:52",
    "code": "688221"
  },
  {
    "title": "前沿生物(688221.SH)2020年度预亏2.2亿-2.4亿元",
    "href": "http://stock.jrj.com.cn/2021/01/20180331730280.shtml",
    "datetime": "2021-01-20 18:03:42",
    "code": "688221"
  },
  {
    "title": "前沿生物：公司抗HIV药物艾博韦泰纳入国家医保目录",
    "href": "http://stock.jrj.com.cn/2020/12/29094731593238.shtml",
    "datetime": "2020-12-29 09:47:10",
    "code": "688221"
  },
  {
    "title": "前沿生物：医保谈判结果出炉 艾博韦泰成功进入国家医保药品目录",
    "href": "http://stock.jrj.com.cn/2020/12/28203631588387.shtml",
    "datetime": "2020-12-28 20:36:39",
    "code": "688221"
  },
  {
    "title": "前沿生物(688221.SH)：注射用艾博韦泰新纳入国家医保目录",
    "href": "http://stock.jrj.com.cn/2020/12/28180831587335.shtml",
    "datetime": "2020-12-28 18:08:05",
    "code": "688221"
  },
  {
    "title": "[前沿生物]医保谈判结果出炉 艾博韦泰成功进入国家医保药品目录",
    "href": "http://stock.jrj.com.cn/2020/12/28000031587655.shtml",
    "datetime": "2020-12-28 00:00:00",
    "code": "688221"
  },
  {
    "title": "[前沿生物]江苏省委组织部领导一行莅临前沿生物调研指导",
    "href": "http://stock.jrj.com.cn/2020/12/13000031483212.shtml",
    "datetime": "2020-12-13 00:00:00",
    "code": "688221"
  },
  {
    "title": "前沿生物携手中国预防性病艾滋病基金会 助力防艾公益事业",
    "href": "http://stock.jrj.com.cn/2020/12/01094031382334.shtml",
    "datetime": "2020-12-01 09:40:01",
    "code": "688221"
  },
  {
    "title": "[前沿生物]创新引领药业前沿 前沿生物在研项目取得阶段性进展",
    "href": "http://stock.jrj.com.cn/2020/12/01000031385142.shtml",
    "datetime": "2020-12-01 00:00:00",
    "code": "688221"
  },
  {
    "title": "[前沿生物]中国预防性病艾滋病基金会与前沿生物签订战略合作意向书",
    "href": "http://stock.jrj.com.cn/2020/11/30000031377967.shtml",
    "datetime": "2020-11-30 00:00:00",
    "code": "688221"
  },
  {
    "title": "艾迪药业：公司产品与前沿生物产品在适应症领域、给药途径以及患者群体方面存在明显不同",
    "href": "http://stock.jrj.com.cn/2020/11/23084831332342.shtml",
    "datetime": "2020-11-23 08:48:29",
    "code": "688221"
  },
  {
    "title": "[前沿生物]不忘初心砥砺前行 前沿生物10月28日成功登陆上交所科创板",
    "href": "http://stock.jrj.com.cn/2020/10/28000031210231.shtml",
    "datetime": "2020-10-28 00:00:00",
    "code": "688221"
  },
  {
    "title": "【兑奖啦】科创板前沿生物网上申购中签号出炉",
    "href": "http://stock.jrj.com.cn/ipo/2020/10/19191031085183.shtml",
    "datetime": "2020-10-19 19:10:38",
    "code": "688221"
  },
  {
    "title": "前沿生物(688221.SH)：网上发行最终中签率为0.03840031%",
    "href": "http://stock.jrj.com.cn/2020/10/18160231075206.shtml",
    "datetime": "2020-10-18 16:02:41",
    "code": "688221"
  },
  {
    "title": "中国艾滋病新药的领军企业前沿生物今日申购，发行价20.50元",
    "href": "http://stock.jrj.com.cn/2020/10/16141931067423.shtml",
    "datetime": "2020-10-16 14:19:58",
    "code": "688221"
  },
  {
    "title": "今日新股申购：前沿生物",
    "href": "http://stock.jrj.com.cn/2020/10/16085831065568.shtml",
    "datetime": "2020-10-16 08:58:00",
    "code": "688221"
  },
  {
    "title": "前沿生物科创板上市将于明日开启申购 华大基因前三季度归母净利润预增逾9倍 | 医资日报",
    "href": "http://stock.jrj.com.cn/2020/10/15184831061578.shtml",
    "datetime": "2020-10-15 18:48:07",
    "code": "688221"
  },
  {
    "title": "前沿生物10月16日申购宝典",
    "href": "http://stock.jrj.com.cn/ipo/2020/10/15144731059761.shtml",
    "datetime": "2020-10-15 14:47:57",
    "code": "688221"
  },
  {
    "title": "前沿生物10月16日申购宝典",
    "href": "http://stock.jrj.com.cn/ipo/2020/10/15144731059760.shtml",
    "datetime": "2020-10-15 14:47:52",
    "code": "688221"
  },
  {
    "title": "前沿生物(688221.SH)：发行价为20.5元/股 10月16日申购",
    "href": "http://stock.jrj.com.cn/2020/10/15010131055021.shtml",
    "datetime": "2020-10-15 01:01:50",
    "code": "688221"
  },
  {
    "title": "前沿生物(688221.SH)：网上路演时间10月15日14:00-17:00",
    "href": "http://stock.jrj.com.cn/2020/10/13190831045136.shtml",
    "datetime": "2020-10-13 19:08:28",
    "code": "688221"
  },
  {
    "title": "前沿生物IPO：核心产品艾可宁打破国外抗艾药垄断局面",
    "href": "http://stock.jrj.com.cn/2020/10/13090031041215.shtml",
    "datetime": "2020-10-13 09:00:22",
    "code": "688221"
  },
  {
    "title": "“抗艾第一股”前沿生物 将于10月13日初步询价",
    "href": "http://stock.jrj.com.cn/2020/10/12115431031038.shtml",
    "datetime": "2020-10-12 11:54:17",
    "code": "688221"
  },
  {
    "title": "前沿生物扭曲的IPO：研发弱靠买专利苦撑 募投产能在掩耳盗铃",
    "href": "http://stock.jrj.com.cn/2020/10/12085131029703.shtml",
    "datetime": "2020-10-12 08:51:35",
    "code": "688221"
  },
  {
    "title": "前沿生物扭曲的IPO：研发弱靠买专利苦撑 募投产能在掩耳盗铃",
    "href": "http://stock.jrj.com.cn/2020/10/12070231074826.shtml",
    "datetime": "2020-10-12 07:02:00",
    "code": "688221"
  },
  {
    "title": "默沙东以42亿美元入局ADC领域 前沿生物科创板IPO注册申请获证监会同意 | 医资日报",
    "href": "http://stock.jrj.com.cn/2020/09/16182130763809.shtml",
    "datetime": "2020-09-16 18:21:24",
    "code": "688221"
  },
  {
    "title": "前沿生物：产品线相对单一 募资超20亿元冲刺科创板IPO | 产业新股",
    "href": "http://stock.jrj.com.cn/2020/09/15114130754050.shtml",
    "datetime": "2020-09-15 11:41:19",
    "code": "688221"
  },
  {
    "title": "[前沿生物]前沿生物创新发展论坛暨生产基地开工仪式在江宁高新区举行",
    "href": "http://stock.jrj.com.cn/2020/09/10000031116476.shtml",
    "datetime": "2020-09-10 00:00:00",
    "code": "688221"
  },
  {
    "title": "前沿生物荣登“中国医药新锐创新力量”10强榜单",
    "href": "http://stock.jrj.com.cn/2020/08/30220530624123.shtml",
    "datetime": "2020-08-30 22:05:56",
    "code": "688221"
  },
  {
    "title": "前沿生物荣登2020年度中国医药新锐创新力量10强榜单",
    "href": "http://stock.jrj.com.cn/2020/08/30212730624029.shtml",
    "datetime": "2020-08-30 21:27:00",
    "code": "688221"
  },
  {
    "title": "[前沿生物]前沿生物荣登2020年度中国医药新锐创新力量10强榜单,展现创新药布局",
    "href": "http://stock.jrj.com.cn/2020/08/30000031116474.shtml",
    "datetime": "2020-08-30 00:00:00",
    "code": "688221"
  },
  {
    "title": "[前沿生物]前沿生物与中信银行南京分行签署战略合作协议",
    "href": "http://stock.jrj.com.cn/2020/08/24000031116477.shtml",
    "datetime": "2020-08-24 00:00:00",
    "code": "688221"
  },
  {
    "title": "前沿生物过会：今年科创板过会第90家 瑞银证券过首单",
    "href": "http://stock.jrj.com.cn/2020/08/07112030448795.shtml",
    "datetime": "2020-08-07 11:20:00",
    "code": "688221"
  },
  {
    "title": "前沿生物科创板二次上会通过 原创抗艾新药获全球多市场专利",
    "href": "http://stock.jrj.com.cn/kcb/2020/08/07102430448324.shtml",
    "datetime": "2020-08-07 10:24:45",
    "code": "688221"
  },
  {
    "title": "前沿生物8月6日科创板首发上会",
    "href": "http://stock.jrj.com.cn/2020/07/29090130370465.shtml",
    "datetime": "2020-07-29 09:01:00",
    "code": "688221"
  },
  {
    "title": "聚焦长效多肽领域的新药研发 前沿生物科创板IPO",
    "href": "http://stock.jrj.com.cn/2020/06/08205929874125.shtml",
    "datetime": "2020-06-08 20:59:35",
    "code": "688221"
  },
  {
    "title": "前沿生物成今年科创板暂缓审议第2家 瑞银证券折戟",
    "href": "http://stock.jrj.com.cn/2020/06/08103529870262.shtml",
    "datetime": "2020-06-08 10:35:00",
    "code": "688221"
  },
  {
    "title": "前沿生物冲刺科创板IPO：持续加强创新药研发与全球商业化",
    "href": "http://stock.jrj.com.cn/2020/06/05140329852112.shtml",
    "datetime": "2020-06-05 14:03:50",
    "code": "688221"
  },
  {
    "title": "前沿生物、凯赛生物6月5日科创板上会",
    "href": "http://stock.jrj.com.cn/2020/05/28090429785181.shtml",
    "datetime": "2020-05-28 09:04:00",
    "code": "688221"
  },
  {
    "title": "前沿生物回复交易所第三轮问询",
    "href": "http://stock.jrj.com.cn/2020/05/25213129762336.shtml",
    "datetime": "2020-05-25 21:31:00",
    "code": "688221"
  },
  {
    "title": "[前沿生物]前沿生物与中国科学院上海药物研究所针对抗2019-nCoV新药开发达成项目合作",
    "href": "http://stock.jrj.com.cn/2020/01/30000031116475.shtml",
    "datetime": "2020-01-30 00:00:00",
    "code": "688221"
  },
  {
    "title": "天智航完成第三轮问询回复 前沿生物状态恢复“已问询”",
    "href": "http://stock.jrj.com.cn/2019/12/17104728545176.shtml",
    "datetime": "2019-12-17 10:47:29",
    "code": "688221"
  },
  {
    "title": "[前沿生物]“为爱前行”公益活动凉山行",
    "href": "http://stock.jrj.com.cn/2019/12/11000031116473.shtml",
    "datetime": "2019-12-11 00:00:00",
    "code": "688221"
  },
  {
    "title": "前沿生物携抗艾新药闯关科创板 独立、持续研发能力遭问询",
    "href": "http://stock.jrj.com.cn/2019/12/03223128485353.shtml",
    "datetime": "2019-12-03 22:31:39",
    "code": "688221"
  },
  {
    "title": "艾可宁之后再未研发新药？ 前沿生物持续研发能力遭质疑",
    "href": "http://stock.jrj.com.cn/2019/12/03143028483184.shtml",
    "datetime": "2019-12-03 14:30:12",
    "code": "688221"
  },
  {
    "title": "[前沿生物]艾可宁被纳入利物浦药物相互作用数据库",
    "href": "http://stock.jrj.com.cn/2019/11/15000031116472.shtml",
    "datetime": "2019-11-15 00:00:00",
    "code": "688221"
  },
  {
    "title": "[前沿生物]前沿生物全注射长效抗艾新药组合获批美国FDA快速通道认定",
    "href": "http://stock.jrj.com.cn/2019/11/07000031116471.shtml",
    "datetime": "2019-11-07 00:00:00",
    "code": "688221"
  },
  {
    "title": "前沿生物、君实生物、神州细胞科创板中止审核",
    "href": "http://stock.jrj.com.cn/2019/10/31202528335016.shtml",
    "datetime": "2019-10-31 20:25:00",
    "code": "688221"
  },
  {
    "title": "[舒泰神]产业为本、金融为器,舒泰神投资标的——前沿生物申报科创板",
    "href": "http://stock.jrj.com.cn/2019/09/16000031822613.shtml",
    "datetime": "2019-09-16 00:00:00",
    "code": "688221"
  },
  {
    "title": "[舒泰神]产业为本、金融为器,舒泰神投资标的——前沿生物申报科创板",
    "href": "http://stock.jrj.com.cn/2019/08/23000030123511.shtml",
    "datetime": "2019-08-23 00:00:00",
    "code": "688221"
  },
  {
    "title": "累亏超4亿 前沿生物闯关科创板",
    "href": "http://stock.jrj.com.cn/kcb/2019/08/19051727993623.shtml",
    "datetime": "2019-08-19 05:17:06",
    "code": "688221"
  },
  {
    "title": "第五套上市标准又一家 前沿生物冲刺科创板",
    "href": "http://stock.jrj.com.cn/kcb/2019/08/15054227978697.shtml",
    "datetime": "2019-08-15 05:42:09",
    "code": "688221"
  },
  {
    "title": "上交所受理前沿生物科创板上市申请：研发我国首个抗艾新药 打破外企垄断",
    "href": "http://stock.jrj.com.cn/2019/08/13180727970728.shtml",
    "datetime": "2019-08-13 18:07:42",
    "code": "688221"
  },
  {
    "title": "上交所受理前沿生物科创板上市申请",
    "href": "http://stock.jrj.com.cn/2019/08/13175327970702.shtml",
    "datetime": "2019-08-13 17:53:00",
    "code": "688221"
  },
  {
    "title": "每经小强快讯：前沿生物药业（南京）股份有限公司科创板首次公开发行股票招股说明书（申报稿）",
    "href": "http://stock.jrj.com.cn/2019/08/13174727970585.shtml",
    "datetime": "2019-08-13 17:47:05",
    "code": "688221"
  },
  {
    "title": "每经小强快讯：进军科创板，前沿生物药业（南京）股份有限公司申请已获上交所受理",
    "href": "http://stock.jrj.com.cn/2019/08/13174627970586.shtml",
    "datetime": "2019-08-13 17:46:21",
    "code": "688221"
  },
  {
    "title": "[前沿生物]前沿生物新型透皮贴片AB001获批中国临床",
    "href": "http://stock.jrj.com.cn/2019/05/25000031116470.shtml",
    "datetime": "2019-05-25 00:00:00",
    "code": "688221"
  },
  {
    "title": "[前沿生物]前沿生物全注射长效抗艾新药组合获批中国临床",
    "href": "http://stock.jrj.com.cn/2019/05/15000031116469.shtml",
    "datetime": "2019-05-15 00:00:00",
    "code": "688221"
  },
  {
    "title": "[前沿生物]前沿生物艾可宁上市入选“2018年度中国十大医学科技新闻”,并被列为年度重大科技创新成果",
    "href": "http://stock.jrj.com.cn/2019/01/23000031116468.shtml",
    "datetime": "2019-01-23 00:00:00",
    "code": "688221"
  },
  {
    "title": "[前沿生物]前沿生物全注射长效抗艾新药组合开始美国II期临床试验",
    "href": "http://stock.jrj.com.cn/2018/12/01000031116467.shtml",
    "datetime": "2018-12-01 00:00:00",
    "code": "688221"
  }
]